A few months ago, around the end of May, a new virus called Monkeypox burst onto the scene. With COVID finally settling down after years, many around the world were distressed by the news to say the least. The good part about monkeypox though is that it is much less deadly that covid. Moreover, the disease has always existed but remained only in Africa for the past 40 years — where it has circulated at low levels. For those looking to get vaccinated against Monkeypox there has been recent good news. Indeed, the Food and Drug Administration has expanded its authorization for the monkeypox vaccine in a way that would significantly boost the limited supply of shots. Moreover, the FDA is now allowing children to receive the vaccine if they are at substantial risk of Monkeypox infection.
Specifically, Dr. Peter Marks, who is the head of the FDA’s vaccine division, has said there will be an increase in exposures among children over the past week. The larger rollout of the vaccine will help combat the spread of the Monkeypox. So far, the HHS has made more than 1 million doses available to state and local health departments since May. Moreover, the 620,000 doses have been shipped to jurisdictions so far, according to HHS.
I am not a financial advisor and my comments should never be taken as financial advice. Investments come with risk, so always do your research and analysis beforehand.